share_log

HC Wainwright & Co. Reiterates Buy on Opus Genetics, Maintains $8 Price Target

Benzinga ·  Dec 12, 2024 11:29  · Ratings

HC Wainwright & Co. analyst Matthew Caufield reiterates Opus Genetics (NASDAQ:IRD) with a Buy and maintains $8 price target.

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Comment Comment · Views 214

Recommended

Write a comment